For every-other-day shampoo users : Apply nightly before bed, regardless of wash day
Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer
Biochim Biophys Acta 139(2):319327 Nunes T, Rocha JF, Vaz-da-Silva M, Igreja B, Wright LC, Falco A, Almeida L, Soares-da-Silva P (2010) Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine--hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects
her dermatologist suspects early female pattern hair loss plus previous nutritional stress
Phase 3 TRIUMPH-4 showed 28.7% weight loss at 68 weeks, substantially exceeding CagriSema's 20.4% at 68 weeks
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS